| Pages | |||
|---|---|---|---|
| Reference and Administrative | Information | ||
| Trustees' Report |
2-4 | ||
| Independent examiner's |
report | ||
| Statement of Financial |
Activities | ||
| Balance Sheet | |||
| Notes to the Financial Statements | 8-14 |
| Reference and Administrative | Reference and Administrative | Information | ||
|---|---|---|---|---|
| for the year ended 5April | 2023 | |||
| Charity Reference: | 1003899 | |||
| Trustees: | Mark Greaves | |||
| Michael Tyler (Chairman) | ||||
| Michael Constant | ||||
| James Naylor | ||||
| Adam Renton | ||||
| Mark Braganza | ||||
| Jon Pleat | ||||
| Address: | Plastic Surgery J | Corridor | ||
| Stoke Mandeville | Hospital | |||
| Mandeville Road |
||||
| Aylesbury | ||||
| HP21 8AL | ||||
| Independent | Examiner: | Wenn Townsend | ||
| 30StGiles | ||||
| Oxford | ||||
| Oxfordshire | ||||
| OX1 3LE | ||||
| Solicitors: | Horwood 8 James | LLP | ||
| 7Temple Square | ||||
| Aylesbury | ||||
| Bucking ham shire |
||||
| HP20 2QB | ||||
| Bankers: | HSBC Bank pic | |||
| 2 Walton Road | ||||
| Aylesbury | ||||
| Bucking ham shire | ||||
| HP21 7SS | ||||
| Investment | managers: | M 8 G Charities | ||
| PO Box9038 | ||||
| Chelmsford | ||||
| Essex | ||||
| CM99 2XF |
| Restore - Burn and Wound Resear | Restore - Burn and Wound Resear | Restore - Burn and Wound Resear | |||||
|---|---|---|---|---|---|---|---|
| Statement ofFinancial Activides | |||||||
| For | the year ended | 5 April 2023 | |||||
| Note | Unrestricted | Restricted | Total | ||||
| funds | funds | 2023 | |||||
| E | E | E | |||||
| Income: | |||||||
| Voluntary income |
2,588 | 2,588 | |||||
| Activities for raising funds | 60,296 | 60,296 | |||||
| Total income | 2,588 | 60,296 | 62,884 | ||||
| Expenditure:- | |||||||
| Costs of raising voluntary |
income | 5 | 1,295 | 1,295 | |||
| Charitable expenditure: |
Burns Research | 6 | 28,257 | 23,123 | 51,380 | ||
| Totalexpenditure | 29,552 | 23,123 | 52,675 | ||||
| Net (expenditure)flncome | (26,964) | 37,173 | 10,209 | ||||
| Net (expenditure)/income | before gains on | ||||||
| investments | (26,964) | 37,173 | 10,209 | ||||
| Unrealised gains/(losses) Realised gains on disposal |
on | investments | 9 9 |
(1,132) (411) |
(1,132) (411) |
||
| (28,507) | 37,173 | 8,666 | |||||
| Transfers between funds |
|||||||
| (28,507) | 37,173 | 8,666 | |||||
| Fund balance brought | forward | 87,966 | 61,153 | 149,119 | |||
| Fund balance carried forward | 59,459 | 98,326 | 157,785 |
| Unrestricted | Restricted | Endowment | Total |
|---|---|---|---|
| funds | funds | funds | 2022 |
| E | E | E | |
| 3,982 | 3,982 | ||
| 27,000 | 27,000 | ||
| 3,982 | 27,000 | 30,982 | |
| 1,218 | 1,218 | ||
| 30,832 | 587 | 31,419 | |
| 32,050 | 587 | 32,637 | |
| (28,068) | 26,413 | (1,655) | |
| (28,068) | 26,413 | (1,655) | |
| 10,926 | 10,926 | ||
| (28,068) | 26,413 | 10,926 | 9,271 |
| 104,834 | (104,834) | ||
| 76,766 | 26,413 | (93,908) | 9,271 |
| 11,200 | 34,740 | 93,908 | 139,848 |
| 87,966 | 61,153 | 149,119 |
| Note | 2023 | 2022 | ||||||
|---|---|---|---|---|---|---|---|---|
| Fixed assets | ||||||||
| Investments Tangible assets |
9 10 |
71,791 2,157 |
103,333 2,876 |
|||||
| Current assets | 73,948 | 106,209 | ||||||
| Debtors HSBC —community Barclays account |
account | 443 85,879 |
929 45,469 174 |
|||||
| 86,322 | 46,572 | |||||||
| Current liabilities | ||||||||
| Creditors | 12 | (2,485) | (3,662) | |||||
| Net current assets | 83,837 | 42,910 | ||||||
| Net assets | 157,785 | 149,119 | ||||||
| Funds | ||||||||
| Expendabie endowment |
funds | |||||||
| Unrestricted funds |
— | General | 13 | 59,459 | ||||
| Designated | 13 | 87,966 | ||||||
| Restricted funds | 14 | 98,326 | 61,153 | |||||
| 157,785 | 149,119 |
| Voluntary | income | |||||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | |||
| 2023 | 2022 | |||||
| E | ||||||
| Donations | and legacies | 2,588 | 2,588 | 2,622 | ||
| Sponsorship | Income | 60,296 | 60,296 | 1,360 | ||
| 2,588 | 60,296 | 62,884 | 3,982 |
| Unrestricted | Restricted | Total | Total | ||||
|---|---|---|---|---|---|---|---|
| 2023 | 2022 | ||||||
| Medical Research Council | 60296 | 60296 | 27000 | ||||
| 60,296 | 60,296 | 27,000 | |||||
| 5. | Costs of raising funds | ||||||
| Unrestricted | Restricted | Total | Total | ||||
| 2023 | 2022 | ||||||
| E | |||||||
| Advertising | and publicity | 432 | 432 | 432 | |||
| Support costs (note | 7) | 204 | 204 | 330 | |||
| Fundraising | |||||||
| Office expenses | 659 | 659 | 456 | ||||
| 1,295 | 1,295 | 1,218 | |||||
| 6. | Charitable | expenditure | |||||
| Total | Total | ||||||
| Unrestricted | Restricted | 2023 | 2022f | ||||
| Fellows' salaries | 22,967 | 22,967 | 579 | ||||
| Director of | Research | 22,000 | 22,000 | 24,000 | |||
| Support costs (note | 7) | 2,354 | 6 | 2,360 | 3,572 | ||
| Research, | equipment | and travel | 150 | 150 | |||
| Prizes awarded | 800 | 800 | 500 | ||||
| Governance | costs (note 7) | 3,103 | 3,103 | 2,768 | |||
| Sponsorship | Refund | ||||||
| 28,257 | 23,123 | 51,380 | 31,419 |
| Costs ofgenerating | Costs ofgenerating | Charitable | Governance | Total | Total | |
|---|---|---|---|---|---|---|
| Funds | expenditure | 2023 E |
2022 f |
|||
| Depreciation | 72 | 575 | 72 | 719 | 959 | |
| Treasurer salary |
100 | 800 | 100 | 1,000 | 1,841 | |
| Secretarial salary and |
expenses | 32 | 260 | 33 | 325 | 500 |
| Auditor's remuneration |
2,898 | 2,899 | 2,438 | |||
| Insurance | 635 | 635 | 617 | |||
| Legal Fees | 300 | |||||
| Bank charges | 90 | 90 | 15 | |||
| 2,360 | 3,103 | 5,668 | 6,670 |
| Investments | ||||
|---|---|---|---|---|
| 2023 | 2022 | |||
| Investments are stated at fair value and movements |
are: | |||
| At 6 April 2022 | 103,333 | 92,407 | ||
| Disposal Proceeds | (29,999) | |||
| Gain on disposal | (1,132) | |||
| Increase/(Decrease) | in market value | (411) | 10,926 | |
| At 5 April 2023 | 71,791 | 103,333 |
| 10. | Tangible fixed assets | |||
|---|---|---|---|---|
| Computer and | ||||
| other equipment | ||||
| Cost: | ||||
| At 6 April 2022 and at | 5 April 2023 | 84,470 | ||
| Depreciation: | ||||
| At 6 April 2022 | 81,594 | |||
| Charge for year | 719 | |||
| At 5 April 2023 | 82,313 | |||
| Net book value: | ||||
| At 5 April 2023 | 2,157 | |||
| At 5 April 2022 | 2,876 | |||
| 11. | Debtors | |||
| 2023f | 2022 f. |
|||
| Prepayments | 443 | 929 | ||
| 443 | 929 | |||
| 12. | Creditors | |||
| Audit and accountancy | accrued | 2,160 | 2,621 | |
| Other accruals | 325 | 1,041 | ||
| 2,485 | 3,662 |
| At | Gain on | At | |||||
|---|---|---|---|---|---|---|---|
| 6April 2022 | Income | Expenditure | investment | Transfer | 5 April 2023 | ||
| F | |||||||
| General fund Designated funds |
87,966 | 2,588 | (29,553) | (1,542) | 87,966 (87,966) |
59,459 | |
| Total unrestricted | funds | 87,966 | 2,588 | (29,553) | (1,542) | 59,459 | |
| At | Gain on | At | |||||
| 6April 2021 | Income F |
Expenditure f |
investment | Transfer F |
5 April 2022 | ||
| General fund |
3,982 | (31,550) | 27,568 | ||||
| Designated funds |
11,200 | (500) | 77,266 | 87,966 | |||
| Total unrestricted | funds | 11,200 | 3,982 | (32,050) | 104,834 | 87,966 |
| Restricted funds | ||||
|---|---|---|---|---|
| BEST" | Immunomodulation | Medical | ||
| Current year | project | project | equipment F. |
Totalf |
| Balance at 6 April 2022 | 13,296 | 47,835 | 22 | 61,153 |
| Income | 33,296 | 27,000 | 60,296 | |
| Expenditure | (150) | (22,967) | (6) | (23,123) |
| Balance at 5 April 2023 | 46,442 | 51,868 | 16 | 98,326 |
| BEST* | Immunomodulation | Medical | ||
| Prior year | project | project | equipment | Total |
| F | ||||
| Balance at 6 April 2021 | 13,296 | 21,414 | 30 | 34,740 |
| Income | 27,000 | 27,000 | ||
| Expenditure | (579) | (8) | (587) | |
| Balance at 5 April 2022 | 13,296 | 47,835 | 22 | 61,153 |
| Division | of net assets between funds | |||
|---|---|---|---|---|
| Current | year | |||
| Unrestricted | Restricted | |||
| funds | funds | Total | ||
| Fixed assets | ||||
| Tangible | fixed assets | 2,141 | 16 | 2,157 |
| Investments | 71,791 | 71,791 | ||
| 73,932 | 16 | 73,948 | ||
| Debtors | 443 | 443 | ||
| Cash at | bank and in hand | (12,431) | 98,310 | 85,879 |
| Creditors | (2,485) | (2,485) | ||
| Net assets | 59,459 | 98,326 | 157,585 | |
| Prior year | ||||
| Unrestricted | Restricted | |||
| funds | funds | Total | ||
| Fixed assets | ||||
| Tangible | fixed assets | 2,854 | 22 | 2,876 |
| Investments | 103,333 | 103,333 | ||
| 106,187 | 22 | 106,209 | ||
| Debtors | 929 | 929 | ||
| Cash at | bank and in hand | (15,488) | 61,131 | 45,643 |
| Creditors | (3,662) | (3,662) | ||
| Net assets | 87,966 | 61,153 | 149,119 |